Zheng Xiangqian
8PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jul 02, 2025
The SOX12-YBX1-LDHA signaling axis drives metastasis in papillary thyroid carcinoma.Xianhui Ruan, Yue Huang, Yu Zeng
|Jun 30, 2025
Enhancer hijacking drives FAM20C expression to promote papillary thyroid cancer progression.Xianhui Ruan, Wei Zhang, Xiukun Hou
|Nov 13, 2024
An Artificial Intelligence-Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma.Qiang Li, Weituo Zhang, Tian Liao
|Aug 30, 2023
METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer.Junya Ning, Xiukun Hou, Jie Hao
|Mar 29, 2023
Targeting Aurora-A inhibits tumor progression and sensitizes thyroid carcinoma to Sorafenib by decreasing PFKFB3-mediated glycolysis.Zhi Jingtai, Hu Linfei, Qian Yuyang
|Dec 13, 2022
To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments.Ying Sun, Wenjun Xie, Ning Kang
Pageof 2
